Congress Down To The Wire On FDA User Fee Reauthorization, SCHIP
This article was originally published in The Gray Sheet
Executive Summary
FDA reform legislation reauthorizing device and drug user fees may not be finalized by Congress in time to avoid agency layoffs
You may also be interested in...
Congress Approves FDA Reform/User Fee Bill In The Nick Of Time
Congress gave final approval last week to a massive FDA bill that renews device and drug user fees for five years and strengthens product safety programs
Congress Approves FDA Reform/User Fee Bill In The Nick Of Time
Congress gave final approval last week to a massive FDA bill that renews device and drug user fees for five years and strengthens product safety programs
House Cuts Imaging Payments To Help Fund Children’s Health Insurance
The House passed a bill Aug. 1 that would severely cut imaging payments to help pay for expanded coverage for children without health insurance and prevent physician payments from dropping in 2008